ClinicalTrials.Veeva

Menu

The Effect of Oral Vitamin D Supplements on Fusion Outcome in Patients Receiving Elective Lumbar Spinal Fusion

S

Show Chwan Memorial Hospital

Status

Completed

Conditions

Spinal Fusion
Vitamin D
Lumbar Spine Disease

Treatments

Dietary Supplement: calcium
Dietary Supplement: vitamin D3

Study type

Interventional

Funder types

Other

Identifiers

NCT05023122
RD105014

Details and patient eligibility

About

The process of bony fusion is a dynamic bone remodeling process and a variety of risk factors have been identified to contribute to pseudoarthrosis.Vitamin D deficiency has been reported to be associated with more pseudoarthrosis, prolonged time to fusion, and poorer spine function and quality of life after spinal fusion.However, as the review article presented, it lacks high-quality evidence to investigate the role of vitamin D supplements in spinal fusion. Therefore, this randomized controlled trial aimed to evaluate the effectiveness of oral vitamin D supplements on fusion outcomes in patients receiving elective lumbar spinal fusion.

Enrollment

34 patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 20 and 80 years
  • Indicated of elective spine fusion surgery for spinal stenosis or degenerative spondylolisthesis at the study hospital from January 2016 to December 2017.

Exclusion criteria

  • Spinal instability due to trauma, infection, or malignancy
  • History of previous spine surgery
  • Hemodialysis
  • Long-term steroid use
  • History of medical treatments for osteoporosis
  • Postoperative follow-up for less than 12 months
  • Newly-onset compression fracture after study procedure

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

34 participants in 2 patient groups

vitamin D3 + calcium
Experimental group
Description:
vitamin D3 (cholecalciferol) 800 IU QD and calcium citrate 600 mg QD, given from postoperative day 1 and lasted for 3 months
Treatment:
Dietary Supplement: calcium
Dietary Supplement: vitamin D3
calcium only
Active Comparator group
Description:
only calcium citrate 600 mg QD, given from postoperative day 1 and lasted for 3 months
Treatment:
Dietary Supplement: calcium

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems